symbol stringlengths 1 9 | title stringlengths 1 701 | text stringlengths 1 140k |
|---|---|---|
TEVA | BioDelivery Sciences settles Bunavail patent dispute with Teva | BioDelivery Sciences NASDAQ BDSI settles its patent infringement litigation with Teva Pharmaceutical Industries NYSE TEVA U S unit related to BUNAVAIL buprenorphine and naloxone Teva had filed a marketing application seeking FDA approval for a generic version of the product Under the terms of the settlement B... |
TEVA | Teva under pressure down 4 | Beleaguered Teva Pharmaceutical Industries TEVA 4 2 is down on below average volume in a retest of the recent low of 15 22 touched on September 6 Shares are currently exchanging hands at 15 05 a 52 week low No particular news accounts for the action Earlier today the company settled its patent challenge with ... |
TEVA | Teva submits U S marketing application for migraine med fremanezumab | Teva Pharmaceutical Industries TEVA files its Biologics License Application BLA with the FDA seeking approval for fremanezumab for the prevention of migraine Fremanezumab administered once per month via subcutaneous injection is a monoclonal antibody that binds to a compound called calcitonin gene related peptide... |
TEVA | Innovus Pharma s Vesele OK d in Canada shares ahead 7 | Health Canada approves Innovus Pharmaceuticals OTCQB INNV 6 7 Vesele an over the counter natural health product to treat sexual dysfunction The company plans to launch the product directly through its Beyond Human sales and marketing platform and through other sales channels Now read |
XOM | New Jersey lawmakers send post Exxon pollution bill to governor | By Hilary Russ Reuters New Jersey lawmakers sent a bill to Governor Chris Christie on Thursday that calls for more money from environmental settlements to fund cleanups The legislation came after the Christie administration announced a controversial 225 million deal with Exxon Mobil Corp NYSE XOM on March 5 o... |
MRO | Why Is Marathon Oil MRO Stock Rallying Today | On Monday shares of leading exploration and production company Marathon Oil Corp NYSE MRO are rallying up over 10 in afternoon trading after the company announced it had agreed to acquire PayRock Energy for 888 million from EnCap investments a private equity firm
Under the deal Marathon will receive roughly... |
MRO | Marathon Oil Upped To Buy On Positive Estimate Revisions | On Jul 5 Zacks Investment Research upgraded Marathon Oil Corporation NYSE MRO to a Zacks Rank 2 Buy Crude Improvement Means Good News for Marathon OilOver the last 60 days the Zacks Consensus Estimate of Marathon Oil for the third quarter of this year saw an improvement from a loss of 34 cents to a loss of 28 ... |
XOM | ETFs For The Unquestioned Wall Of Worry | The crises of yesteryear almost seem quaint Did investors really need to fret the possibility of the world s 44th economy Greece exiting the euro zone back in 2011 The stock market ultimately prevailed Why did the fiscal cliff sequestration and government shutdown concerns cause so much anxiety in 2012 U S stoc... |
TEVA | Teva s Q1 Earnings Could Show CEO Schultz s Turnaround Still On Track | Reports Q1 2019 results on Thursday May 2 before the market open Revenue Expectation 4 38 billion EPS Expectation 0 58
Teva Pharmaceuticals NYSE TEVA turnaround has been a tough sell for its Chief Executive Officer Kare Schultz at least in 2019
The share price of the world s largest manufacturer of gene... |
TEVA | Teva TEVA Beats On Q1 Earnings Misses Sales Shares Down | Israel based Teva Pharmaceutical Industries Ltd NYSE TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets The company s branded products include Copaxone multiple sclerosis Austedo chorea associated with Huntington s disease and tardive dyskinesia and resp... |
TEVA | Teva gets new CEO reports positive fremanezumab study shares jump | Investing com Shares of Teva Pharma Industries Ltd ADR NYSE TEVA rallied on Monday after the company released positive results from its trial on fremanezumab for the prevention of migraines and announced the appointment of a new CEO
Pre bell Teva announced that Kare Schultz will be its new chief executive Schult... |
TEVA | Premarket Gainers as of 9 05 am | ALDX 53 on its lead product candidate successful in mid stage dry eye study AEMD 47 as FDA designates Aethlon Hemopurifier for accelerated review CTIC 7 on positive analyst action TA 7 on the announcement that it has won its litigation against Comdata TEVA 6 on selling Paragard asset to CooperSurgical fo... |
TEVA | Teva sells remaining assets in women s health unit for 1 38B shares ease 1 premarket as RBC says turnaround to be prolonged | Teva Pharmaceutical Industries NYSE TEVA inks two agreements to sell the remaining assets in its specialty global women s health business for 1 38B Proceeds including the recently announced sale of PARAGARD will be used to pay down debt
The first deal involves the sale of a portfolio of products including Ovale... |
TEVA | Teva teams up with Nuvelution Pharma to accelerate development of Austedo for Tourette syndrome shares up 1 | Teva Pharmaceutical Industries TEVA 0 7 inks an agreement with privately held Nuvelution Pharma aimed at accelerating development of AUSTEDO deutetrabenazine for the treatment of a movement disorder called Tourette syndrome Under the terms of the agreement Nuvelution will fund and manage clinical development whi... |
XOM | New Jersey environmental bills move ahead with Exxon deal pending | By Hilary Russ NEW YORK Reuters A New Jersey bill that calls for more money from environmental settlements to fund cleanups moved to the full state Assembly on Thursday in the wake of a controversial 225 million deal with Exxon Mobil Corp NYSE XOM A state Assembly committee released the bill which was alread... |
CSCO | High Beta Currencies Benefitting The Most From US Data | EUR 10 Year Spanish Yields at 2 Month Low GBP Lifted by Another Piece of Good News CAD Surprise Decline in Manufacturing Sales NZD Job Ads Rebound AUD Slower Consumer Inflation Expectations and Average Wages JPY Yen Crosses Lifted by Chinese Comments High Beta FX Benefitting the Most from US Data After more than ... |
CSCO | Stocks Get A Boost From Cisco Merkel Close Higher | U S stock indexes rose Thursday boosted by the tech sector and reassuring comments from German Chancellor Angela Merkel Stocks looked past this morning s disappointing economic data which included housing starts jobless claims and mid Atlantic factory activity Cisco Systems CSCO shares led the Dow Jones Indust... |
XOM | The 3 Macro Questions Investors Must Ask Heading Into 2015 | I am ecstatic that the majority of my client base had 65 70 long exposure in lower volatility stock ETFs over the last two trading sessions The S P 500 picked up roughly 4 5 which means that these portfolio balances rose approximately 3 0 since the U S Federal Reserve promised to be patient with respect to rai... |
TEVA | Jazz Pharmaceuticals Sleep Drug NDA Awaits FDA Decision | Jazz Pharmaceuticals plc s NASDAQ JAZZ NDA for lead pipeline candidate solriamfetol JZP 110 awaits FDA decision on Wednesday The new drug application NDA under review seeks approval of the drug as a treatment to improve wakefulness and reduce excessive daytime sleepiness EDS in adult patients with narcol... |
TEVA | Jazz s Xyrem Follow On Drug Succeeds In Phase III Study | Jazz Pharmaceuticals plc NASDAQ JAZZ announced positive top line data from a phase III study evaluating its sleep disorder candidate JZP 258 Data showed that treatment with the candidate achieved clinically meaningful maintenance of efficacy in adult patients suffering from cataplexy and excessive daytime sleepin... |
TEVA | BioDelivery BDSI Buys US Rights To Pain Drug For 30M | BioDelivery Sciences International Inc NASDAQ BDSI announced that it has inked an exclusive licensing agreement with Japanese pharma company Shionogi acquiring U S commercial rights to the latter s tablet for opioid induced constipation OIC Symproic naldemedine Symproic is an innovative approved for trea... |
TEVA | Teva launches latest generic shares higher in response | Investing com Teva Pharma Industries Ltd ADR NYSE TEVA has launched its generic version of Eli Lilly s Axiron topical solution CIII in the U S Axiron is I used to treat adult men with low or no testosterone The U S market is worth approximately 247 million according to IMS
Teva s shares were up over 1 follo... |
TEVA | Companies eyeing Teva s women s health assets Bloomberg | Bloomberg reports that health products firms Church Dwight CHD and The Cooper Companies COO 0 3 are mulling bids for Teva Pharmaceutical Industries TEVA 0 8 women s health portfolio estimated to be worth 2B Teva may sell the unit as one or split the U S and European businesses to accommodate the specifi... |
TEVA | Credit Suisse softens view on Teva sees 21 downside risk shares down 2 premarket | Bearish sentiment is still dogging Teva Pharmaceutical Industries NYSE TEVA This morning Credit Suisse SIX CSGN downgraded the stock to Underperform and lowered its price target to 13 21 downside risk from 25
Analyst Vamil Divan says the company s core challenge is not going to fade anytime soon citing... |
TEVA | Teva finally gets a new CEO | Ending months of speculation over who will lead the drugmaker TEVA has named Kare Schultz as its new chief executive as it struggles under the weight of an acquisition streak generic competition and tough pricing environment
The healthcare veteran joins the company with about 30 years of experience in the industry ... |
XOM | Bells toll for Europe s largest gas field | By Toby Sterling WESTERWIJTWERD Netherlands Reuters Dutch church bells that for centuries have tolled to warn of floods across the low lying countryside are sounding the alarm for a new threat earthquakes linked to Europe s largest natural gas field Money can buy a lot of things but a building like this cannot... |
XOM | Crude Oil remains unchanged in spite of attacks on Libyan oil fields | Investing com Crude oil prices remained virtually unchanged on Thursday in spite of continuing attacks by Islamic State militants that have forced the closure of nearly a dozen oil fields in Libya over the last week
On the Intercontinental Exchange ICE brent crude oil for April delivery traded at 61 21 in U S ... |
XOM | NYMEX crude gains in Asia as investors eye demand prospects | Investing com Crude oil in Asia rose on Friday with support coming from foreasts that demand may soak up surplus supplies as central banks round the globe spur easy policies to boost growth WTI crude oil on The New York Mercantile Exchange rose 0 64 to 51 09 a barrel On the Intercontinental Exchange ICE Brent cr... |
XOM | Are Oil Stock Dividends Safe | I pride myself on maintaining emotional detachment when I invest Markets are emotional and tend to overreact and when they do the levelheaded among us use it as an opportunity As Warren Buffett famously said the secret to his success is being greedy when others are fearful and fearful when others are greedy
With ... |
XOM | The Alice In Wonderland World Of The Markets A Return To Reality | If you have ever read any of the enchanting and enduring books by Lewis Carroll you might be excused for thinking that you had indeed fallen asleep and entered the wonderland world with Alice and joined the Mad Hatters tea party the White Rabbit and the Queen of Hearts with all the courtiers After such a week it is... |
XOM | Earn Income From The Energy Crash | If you mention oil or gas stocks to energy investors you re apt to get a big eye roll
Prices for commodities are plunging and it takes a brave soul to venture out looking for bargains
With that said there are several opportunities for you to consider right now ones that many investors are overlooking in this t... |
TEVA | Teva Pharmaceutical Industries Ltd TEVA Outpaces Stock Market Gains What You Should Know | Teva Pharmaceutical Industries Ltd NYSE TEVA closed the most recent trading day at 16 64 moving 0 79 from the previous trading session This change outpaced the S P 500 s 0 37 gain on the day Elsewhere the Dow gained 0 25 while the tech heavy Nasdaq added 0 34
Prior to today s trading shares of the compa... |
TEVA | AstraZeneca says CEO Pascal Soriot will host earnings call | By Kate Holton and Paul Sandle LONDON Reuters Anglo Swedish pharmaceutical firm AstraZeneca L AZN said on Friday its chief executive Pascal Soriot would host a results call with reporters on July 27 after refusing to comment on speculation this week that he was leaving the firm An report on Wednesday on Israe... |
TEVA | AstraZeneca CEO reassures staff aims to be at September cancer meet | By Ben Hirschler LONDON Reuters AstraZeneca Chief Executive Pascal Soriot responding to rumors he might leave the drugmaker to join rival Teva Pharmaceutical Industries NYSE TEVA has told staff he expects to work together with employees to see the company succeed A company spokeswoman added he was intending to... |
TEVA | Teva to proceed with Rimsa breach of contract suit after ruling | By Steven Scheer JERUSALEM Reuters Teva Pharmaceutical Industries TA TEVA said on Thursday it would continue to pursue a breach of contract suit against the former owners of its Rimsa plant in Mexico after a New York judge rejected Teva s claim of fraud Israel based Teva N TEVA the world s largest generic dru... |
TEVA | Healthcare Top 5 Gainers Losers as of 11 00 am | Gainers OSUR 18 AEZS 12 WMGI 9 PACB 9 OMED 8 Losers AGRX 26 PMD 20 TEVA 18 GKOS 11 MASI 9 Now read |
TEVA | Teva s shares plunge after earnings miss lowered guidance | Investing com Teva Pharma Industries Ltd ADR NYSE TEVA stock is seeing a big sell off on Thursday as traders reacted to the company s disappointing second quarter results and lowered full year outlook
Teva posted EPS of 1 02 in the second quarter on revenue of 5 686 billion missing analysts forecast for 1 06 ... |
XOM | Exclusive Exxon wants five year Beaumont pact to avert strikes during buildout sources | By Erwin Seba HOUSTON Reuters Exxon Mobil Corp s N XOM push to persuade workers at its Beaumont Texas refinery to sign a five year contract nearly twice as long as the last one is part of an effort to avert labor stoppages during a possible expansion that could make it the largest such plant in the United Stat... |
XOM | Oil tumbles as huge supplies raise doubts about rally | By Barani Krishnan NEW YORK Reuters The comeback rally in oil paused on Wednesday with crude prices falling 5 percent or more after traders and investors were overwhelmed by the latest estimates for U S supply builds that came in nearly five times above market expectations Benchmark Brent oil fell below the psyc... |
XOM | Blast at Exxon refinery in California could hike gasoline prices | By Nichola Groom TORRANCE Calif Reuters An explosion and fire ripped through a gasoline processing unit at an Exxon Mobil Corp NYSE XOM refinery near Los Angeles on Wednesday leaving California with the threat of higher gasoline prices Investigators were trying to determine the cause of the blast in Torrance ... |
XOM | U S refinery strike passes 18th day but talks resume | By Erwin Seba HOUSTON Reuters The largest U S refinery workers strike since 1980 passed its 18th day on Wednesday but talks between union and oil company representatives over safety and pay restarted after a gap of a week and went into the night according to a union text message More than 5 000 workers at 11 plan... |
MRO | Stock Market Outlook January Decline Suggests Further Losses | Stocks Entering Period of Seasonal Strength Today
Arch Coal Inc NYSE ACI Seasonal Chart
Imperial Oil Limited TSE IMO Seasonal Chart
PPG Industries Inc NYSE PPG Seasonal Chart
Marathon Oil Corporation NYSE MRO Seasonal Chart
Marsh McLennan Companies Inc NYSE MMC Seasona... |
XOM | Dow Jones Analysis 5 Day Streak Is Broken | Dow JonesThe Dow ended slightly lower on Wednesday breaking their five day streak of record closing highs as energy and utility shares lost ground U S stocks ended Wednesday mixed to lower after lackluster European data gave investors reason to sell equities for profits Energy shares fell along with oil prices wit... |
XOM | Contrarian Investing What Would Warren Do | About three weeks ago I wrote about possible contrarian plays in the oil patch see Do you have what it takes to be a contrarian investor I had pointed out that Warren Buffett had taken large stakes in Suncor NYSE SU and ExxonMobil NYSE XOM in Q2 2013 and the closing price of those stocks are approaching the to... |
TEVA | Teva TEVA Misses On Q4 Earnings Beats Sales Shares Down | Israel based Teva Pharmaceutical Industries Ltd NYSE TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets The company s branded products include Copaxone multiple sclerosis Azilect Parkinson s disease Austedo chorea associated with Huntington s disease a... |
TEVA | Teva Tanks As Downside Risk Grows | Summary
Teva Pharmaceutical NYSE TEVA fell 9 on Wednesday morning after it posted earnings that missed Wall Street expectations
The stock s market cycles point to a period of increasing risk as the current cycle matures resuming a declining phase
Teva reported earnings per share of 0 53 and total revenue of 4... |
TEVA | What s In The Cards For Amarin AMRN This Earnings Season | Amarin Corporation PLC NASDAQ AMRN is likely to report its fourth quarter 2018 earnings soon Amarin s earnings performance in the last four quarters was dismal with the company missing estimates twice meeting the same on one occasion and beating the same on the other delivering an average negative surprise of 1... |
TEVA | KemPharm on deck to present data on hydromorphone prodrug KP511 | KemPharm KMPH announces that it will present clinical data on KP511 its prodrug of opioid hydromorphone at the International Conference on Opioids in Boston June 11 13 Investor interest should pick up in companies developing alternatives to traditional opioid pain killers after the FDA s action to remove Endo s EN... |
TEVA | Teva s candidate for topical treatment of PHN flunks mid stage study licensor Xenon Pharmaceuticals down 22 | Thinly traded nano cap Xenon Pharmaceuticals XENE 22 4 slumps on a 13x surge in volume after Teva Pharmaceutical Industries TEVA 1 5 announced that its candidate for the topical treatment of postherpetic neuralgia PHN TV 45070 failed to beat placebo in Phase 2 clinical trial Teva licensed the candidate a... |
TEVA | AstraZeneca s CEO Soriot to join Israeli drugs company Teva report | TEL AVIV Reuters Israel based Teva Pharmaceutical Industries TA TEVA will name AstraZeneca L AZN chief executive Pascal Soriot as its next CEO the Calcalist financial news website said on Wednesday Soriot has met with Teva N TEVA representatives and expressed his agreement to serve as its next CEO Soriot i... |
TEVA | Daimler slips miners provide support as European shares pause for breath | LONDON Reuters European shares inched higher on Thursday with investors less keen to chase the previous session s strong rally that came on the back of the relatively dovish tone struck by Fed chair Janet Yellen overnight The pan European STOXX 600 was up 0 1 percent in line with euro zone stocks and blue chips ... |
TEVA | AstraZeneca offers no comment after report saying CEO staying | LONDON Reuters Anglo Swedish pharmaceutical firm AstraZeneca L AZN declined to comment on speculation about the future of its chief executive Pascal Soriot on Friday after a report quoted Bloomberg news agency saying he would stay in his post The StreetInsider com citing Bloomberg said Soriot was currently pl... |
TEVA | AstraZeneca says CEO Pascal Soriot to host call on results | LONDON Reuters Anglo Swedish pharmaceutical firm AstraZeneca L AZN said on Friday its chief executive Pascal Soriot would host a results call with reporters on July 27 after refusing to comment on speculation this week that he was leaving the firm AstraZeneca will announce its first half 2017 financial results... |
XOM | Exclusive Russia s Rosneft will not resume drilling in Kara Sea in 2015 sources | By Denis Pinchuk and Katya Golubkova MOSCOW Reuters Russian state controlled oil company Rosneft MM ROSN will not be able to resume drilling in the Kara Sea this year after Western sanctions halted its cooperation with ExxonMobil N XOM in a major setback for Moscow s energy ambitions two company sources said ... |
XOM | Exxon Mobil Q4 EPS 1 56 vs expectations of 1 34 | Investing com The world s largest oil and gas company Exxon Mobil NYSE XOM reported better than expected fourth quarter earnings ahead of Monday s opening bell sending its shares higher in pre market trade
Exxon said earnings per share came in at 1 56 above expectations for earnings of 1 34 per share
The comp... |
XOM | Exxon quarterly profit lower share buyback cut | Reuters Exxon Mobil Corp said on Monday its quarterly profit fell 21 percent as weak oil prices took a toll but results topped Wall Street expectations due to tax benefits and a favorable arbitration ruling Global oil markets are over supplied at a time when demand is waning a situation that has caused crude pri... |
XOM | Exxon Mobil More Downside In The Cards | Traders and investors should note the major integrated energy stocks have been coming under selling pressure lately The leading integrated energy stock in the market is Exxon Mobil Corp NYSE XOM This market leading energy stock has now formed a weekly chart bear flag pattern Bear flags are a very significant patt... |
XOM | China s Next Energy Boom | China has a massive problem
In an effort to reduce pollution the country is slowing its Crude Oil consumption and switching to Natural Gasinstead
But if the current trend holds China will be forced to pay a heavy price for its new found environmental conscience
Why Simple supply and demand
China s natural gas pr... |
XOM | Energy Stocks May Be Ready To Surge | The United States Oil Fund NYSE USO made a fresh low Wednesday then tagged an important support level on the charts Meanwhile Exxon Mobil NYSE XOM was looking at a higher low on the daily chart an important milestone as it tells us that energy stocks which have been down quite bit over the past 6 weeks cou... |
XOM | Will One Company s Liquids Gamble Pay Off | As a major dry gas producer Encana NYSE ECA has suffered for years under the weight of low margin natural gas
In the process its peers sprinted forward by drilling for liquids Well the company made a dramatic switch and has completely refocused its operations squarely on oil and gas liquids It s been selling an... |
TEVA | Teva Stock Is Still Cheap Q4 Earnings Should Show Turnaround Progress | Reports Q4 2018 results on Wednesday Feb 13 after the market close
Revenue Expectation 4 53 billion
EPS Expectation 0 54
Teva Pharmaceutical NYSE TEVA is showing great momentum this year Its shares are up about 25 percent so far in 2019 more than 5x the levels the benchmark S P 500 is up
Teva is tryin... |
TEVA | Teva Pharmaceutical Industries Ltd TEVA Stock Sinks As Market Gains What You Should Know | Teva Pharmaceutical Industries Ltd NYSE TEVA closed the most recent trading day at 19 70 moving 0 76 from the previous trading session This move lagged the S P 500 s daily gain of 0 09 Elsewhere the Dow gained 0 26 while the tech heavy Nasdaq lost 0 25
Coming into today shares of the company had gained ... |
TEVA | Why The Earnings Surprise Streak Could Continue For Teva Pharmaceutical Industries Ltd TEVA | If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report you should consider Teva Pharmaceutical Industries Ltd NYSE TEVA This company which is in the Zacks Medical Generic Drugs industry shows potential f... |
TEVA | Israel stocks lower at close of trade TA 35 down 0 91 | Investing com Israel stocks were lower after the close on Wednesday as losses in the Real Estate Technology and Communication sectors led shares lower
At the close in Tel Aviv the TA 35 declined 0 91
The best performers of the session on the TA 35 were Bezeq Israeli Telecommunication Corp Ltd TA BEZQ which r... |
TEVA | Teva Pharm search committee recommends foreigner for CEO report | TEL AVIV Reuters Teva Pharmaceutical NYSE TEVA Industries TA TEVA search for a new chief executive has resulted in the selection of a foreigner as the leading candidate Israeli financial news website Calcalist said on Thursday Separately three candidates are vying for the position of chief financial officer... |
TEVA | Israel stocks lower at close of trade TA 35 down 0 53 | Investing com Israel stocks were lower after the close on Thursday as losses in the Communication Insurance and Technology sectors led shares lower
At the close in Tel Aviv the TA 35 lost 0 53
The best performers of the session on the TA 35 were Azrieli Group Ltd TA AZRG which rose 2 71 or 550 points to t... |
TEVA | Teva s fremanezumab successful in late stage migraine study U S marketing application expected this year shares up 1 | A Phase 3 clinical trial HALO assessing Teva Pharmaceutical Industries TEVA 0 5 fremanezumab for the prevention of migraine met all primary and secondary endpoints Patients treated with the monoclonal antibody experienced a statistically significant reduction in the number of monthly headache days of a least mo... |
TEVA | Teva s migraine candidate fremanezumab successful in second late stage study shares ahead 1 premarket | Teva Pharmaceutical Industries NYSE TEVA is up 1 premarket on light volume in response to its announcement of positive results in a second Phase 3 study HALO assessing fremanezumab TEV 48125 for the prevention of migraine Fremanezumab administered once month showed superiority to placebo as measured by change fr... |
TEVA | Teva to nominate new directors | In the latest step toward remaking the company Teva Pharmaceutical NYSE TEVA will seek to overhaul its board by nominating four new directors Among their first orders of business would be picking a new chief executive We are evolving the board to meet new challenges both within Teva and the business of generic dru... |
TEVA | Teva launches generic eye drop Pataday in U S | Teva Pharmaceutical Industries NYSE TEVA commences the commercial launch of its generic version of Novartis Pataday olopatadine hydrochloride ophthalmic solution 0 2 in the U S for the treatment of ocular itching associated with allergic conjunctivitis According to IMS Health the U S market is 303M Now read |
XOM | Wall Street up more than 1 percent boosted by jobs data Fed | By Caroline Valetkevitch NEW YORK Reuters U S stocks rebounded on Wednesday from five straight sessions of losses after strong private sector jobs data and as minutes from the most recent Federal Reserve meeting reassured investors the bank was in no hurry to start raising interest rates The S P 500 rose 1 2 pe... |
XOM | As oil plummets how much pain still looms for U S energy firms | By Edward McAllister and David Randall NEW YORK Reuters With nearly a quarter of U S energy shares value wiped out by oil s six month slide investors are wondering if the sector has taken enough punishment and whether it is time to pile back in ahead of earnings reports later this month The broad energy S P 150... |
MRO | Change Of Character For Marathon Oil | Marathon Oil MRO is engaged in the oil and gas exploration and production business the stock is a member of the S P 500 and it has been one of the worst performing stocks in the index in the last 3 months However a possible character change might be taking place in the stock As you can see clearly from the chart b... |
MRO | Northern Tier Energy LP NTI IPO Report | Based in Ridgefield CT Northern Tier Energy LP NTI scheduled a 326 million IPO with a market capitalization of 1 8 billion at a price range mid point of 20 for Thursday July 26 2012 NTI is an independent downstream energy company with refining retail and pipeline operations CONCLUSIONAvoid the NTI IPO see ... |
XOM | Will ExxonMobil Beat Earnings Estimates this Season | The largest publicly traded integrated oil and gas company ExxonMobil Corporation NYSE XOM is set to release its second quarter 2014 results on Jul 31 In the preceding three month period Range Resources delivered a positive earnings surprise of 11 70 the third outperformance in the last 4 quarters buoyed by st... |
XOM | Should You Buy Exxon Ahead Of Earnings | Investors are always looking for stocks that are poised to beat at earnings season and Exxon Mobil Corporation NYSE XOM may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Exxon Mobil is seeing favorable earnings estimate rev... |
XOM | LNG s Future Looks Bleak | Conventional wisdom says that liquefied natural gas LNG is a can t lose proposition
After all Natural Gas is plentiful And liquefying it for transport to countries that are willing to pay through the nose for it seems like a no brainer
Everyone wants in on the game too
When I spoke about natural gas at a ... |
XOM | CGX Energy s Shares Up 100 Since March | CGX Energy Inc TO OYL holds a 100 working interest in two offshore blocks and a 62 working interest in an onshore concession Image CGX Energy Inc
Since we interviewed CGX Energy sPresident and CEO Dewi Jones in March read Small cap investors should watch CGX Energy Huge potential should they find a farm ou... |
XOM | Exxon Mobil s Weakness Continues Watch These Levels | The leading integrated energy company Exxon Mobil Corporation NYSE XOM is trading lower by 0 23 cents to 99 26 a share Exxon Mobil has been very weak since July 31 when it plunged lower on heavy volume Currently the stock is trading below the important 50 day moving average which is a sign of weakness Tod... |
TEVA | Regeneron Sanofi Restructure Immuno Oncology Collaboration | Regeneron Pharmaceuticals Inc NASDAQ REGN and partner Sanofi NASDAQ SNY announced that both the companies have restructured their existing global Immuno oncology Discovery and Development Agreement for new immuno oncology cancer treatments
The original agreement which was signed in 2015 is scheduled to end... |
TEVA | Teva Pharmaceutical Industries Ltd TEVA Gains As Market Dips What You Should Know | Teva Pharmaceutical Industries Ltd NYSE TEVA closed the most recent trading day at 18 45 moving 1 54 from the previous trading session This change outpaced the S P 500 s 0 02 loss on the day Meanwhile the Dow lost 0 03 and the Nasdaq a tech heavy index lost 0 21
Coming into today shares of the company... |
TEVA | Teva Pharmaceutical Industries Ltd TEVA Gains But Lags Market What You Should Know | In the latest trading session Teva Pharmaceutical Industries Ltd NYSE TEVA closed at 18 76 marking a 0 59 move from the previous day This move lagged the S P 500 s daily gain of 0 76 Elsewhere the Dow gained 0 67 while the tech heavy Nasdaq added 0 71
Heading into today shares of the company had gained... |
TEVA | Israel stocks higher at close of trade TA 35 up 0 34 | Investing com Israel stocks were higher after the close on Wednesday as gains in the Insurance Financials and Banking sectors led shares higher
At the close in Tel Aviv the TA 35 rose 0 34
The best performers of the session on the TA 35 were Partner TA PTNR which rose 4 63 or 81 points to trade at 1829 at t... |
TEVA | Israel stocks higher at close of trade TA 35 up 0 05 | Investing com Israel stocks were higher after the close on Monday as gains in the Technology Banking and Biomed sectors led shares higher
At the close in Tel Aviv the TA 35 added 0 05 to hit a new 1 month high
The best performers of the session on the TA 35 were Frutarom TA FRUT which rose 1 89 or 400 poi... |
XOM | White House has not yet decided on Russia sanctions bill | By Patricia Zengerle WASHINGTON Reuters The White House said on Monday that President Barack Obama had not yet decided how to respond to a bill authorizing new sanctions against Russia over its activities in Ukraine although some lawmakers said they expected he would sign the measure into law This is something... |
MRO | Three Oil E P Companies That Might Offer Investor Opportunities | Oil prices are rising but analyst estimates for oil companies EPS have not followed last week on TradingFloor com Mixed EPS momentumTaking a dive from the overall oil industry level to company specific EPS estimates reveals that in many cases they are being revised downwards see chart 1 It was a surprise to me to ... |
MRO | The Best Mining And Energy Stock Bargains On The Market | There s an old saying on Wall Street that investors should look to the income statement for upside and the balance sheet for downside protection But for mining and energy stocks this axiom has been spun on its head Income statement metrics are forcing many of these stocks down but their balance sheets point to the ... |
XOM | Exxon Mobil Corp Retreats At Double Top Resistance | This morning leading integrated energy stock Exxon Mobil Corp NYSE XOM is declining lower by 0 86 cents to 102 07 a share The stock looks to be pulling back from a double top resistance area on the daily chart from May 8 2014 It should be noted that Exxon Mobil Corp stock is still trading above its daily chart 2... |
XOM | Fed Minutes Boost Trading In These ETFs | Investors heaved a sigh of relief yesterday following the minutes from the Fed meeting held last month The minutes revealed that the Fed is in no hurry to raise interest rates and has maintained its accommodative stance The minutes also suggest that the Fed is on track to pull the world s largest economy out of an er... |
TEVA | Should Value Investors Buy Teva Pharmaceutical Industries Ltd TEVA Stock | While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks we also know that investors tend to develop their own individual strategies With this in mind we are always looking at value growth and momentum trends to discover great companies
Of these value inve... |
TEVA | Teva Pharm says media reports of up to 6 000 layoffs incorrect | JERUSALEM Reuters Teva Pharmaceutical Industries TA TEVA plans to end unprofitable activities and freeze recruitment but said Israeli media reports of up to 6 000 layoffs were incorrect Earlier on Thursday two of Israel s leading financial news websites carried separate reports that Teva the world s biggest ... |
TEVA | FDA OKs Teva s Austedo for HD chorea shares ahead 2 premarket | Teva Pharmaceutical Industries NYSE TEVA is up 2 premarket on modestly higher volume in response to its announcement that the FDA has approved AUSTEDO deutetrabenazine tablets for the treatment of chorea abnormal involuntary movements associated with Huntington s disease HD an Orphan Drug indication
HD is a ... |
TEVA | Teva launches new asthma meds | Teva Pharmaceutical Industries TEVA 0 3 announces the simultaneous U S launch of AirDuo RespiClick fluticasone propionate and salmeterol and its authorized generic for the treatment of asthma patients at least 12 years old who are inadequately controlled on an inhaled corticosteroid or whose disease severity war... |
TEVA | Israel stocks lower at close of trade TA 35 down 0 57 | Investing com Israel stocks were lower after the close on Sunday as losses in the Insurance Oil Gas and Banking sectors led shares lower
At the close in Tel Aviv the TA 35 lost 0 57
The best performers of the session on the TA 35 were Teva TA TEVA which rose 1 06 or 120 points to trade at 11400 at the clo... |
TEVA | Teva Pharmaceutical CFO to step down media | TEL AVIV Reuters The chief financial officer of Teva Pharmaceutical NYSE TEVA Industries TA TEVA Eyal Desheh is stepping down and will likely be appointed chairman of Isracard Bank Hapoalim s TA POLI credit card company Israeli news websites reported on Tuesday Desheh joined Teva as CFO in 2008 and brief... |
XOM | U S Congress readies new sanctions on Russia | By Timothy Gardner WASHINGTON Reuters U S lawmakers were expected on Friday to approve new sanctions on Russian weapons companies and investors in the country s high tech oil projects putting more U S pressure on President Vladimir Putin for interference in eastern Ukraine Late on Thursday the Senate and Ho... |
XOM | Geopolitics Friends Not Enemies Pose More Difficult Challenge | What ultimately led US President Nixon to close the gold window was not its Cold War rival Russia Rather it was US European allies who wanted to exchange their dollars for gold beyond levels that the US was prepared to accept This has been a consistent theme through today
As the German foreign minister put it Europ... |
XOM | The Top Plays For Russia s 400 Billion China Deal | Last week Russian President Vladimir Putin announced that he would accept the outcome of the Ukrainian elections and begin pulling Russian troops back
Don t be fooled though The timing of that statement was no coincidence
It came as Russia signed a new 400 billion energy deal with China which will see it suppl... |
XOM | Apocalypse Now Maybe Later Probably Never | I have been thinking about the kind of tail risk posed by sudden events that could tank global risk appetite and therefore the financial markets My conclusion is that the so called tail risks are wrong and the immediate threat posed by tail risk is lower than the market thinks Let me explain There are three sources ... |
TEVA | Regeneron REGN Rides On Eylea And Dupixent s Performance | Shares of Regeneron Pharmaceuticals Inc NASDAQ REGN have gained 11 in the past six months against a decline of 9 6 for the
Tarrytown New York based Regeneron s key areas of focus include eye diseases heart diseases allergic and inflammatory diseases pain cancer infectious diseases and rare diseases
... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.